國家衛生研究院 NHRI:Item 3990099045/13784

NHRI > National Institute of Environmental Health Sciences > Pau-Chung Chen > Periodical Articles > Item 3990099045/13784

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/13784

Title:	Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder
Authors:	Chiu, WC;Shan, JC;Yang, YH;Chen, VCH;Chen, PC
Contributors:	National Institute of Environmental Health Sciences
Abstract:	Background: Alcohol-related liver disease (ALD) is the most common cause of liver disease. No medication can improve ALD and abstinence from alcohol is the sole effective strategy. Statin use has been demonstrated to have protective effects against liver cirrhosis and hepatocellular carcinoma (HCC) in patients with virus-related liver diseases. Whether statin use has a similar association among patients with alcohol use disorder (AUD) that can lead to ALD, is unknown. Method: We conducted a population-based cohort study using Taiwan's National Health Insurance Research Database from 1997 to 2013 to compare risks of decompensated liver cirrhosis and hepatocellular carcinoma (HCC) between the statin exposed and unexposed groups in the patients with AUD. The incidence rates of decompensated liver cirrhosis and HCC were calculated between patients exposed and unexposed to statins with 1:4 propensity score matching. Cox proportional hazard regressions were performed to evaluate hazard ratios (HRs). Results: The incidence rates of decompensated liver cirrhosis and HCC in the statin-exposed group differed from those in the unexposed group (decompensated cirrhosis: 269.9 vs. 628.9 cases per 100,000 person-years; HCC: 116.7 vs. 318.3 cases per 100,000 person-years). The HRs for decompensated liver cirrhosis and HCC were 0.43 (95% CI, 0.37-0.51) and 0.40 (95% CI, 0.31-0.51), respectively, after adjustment. Conclusions: Statin use was associated with reduced risk of decompensated liver cirrhosis and HCC among AUD patients in a cumulative dose effect manner. Statins might have some potential effects on mitigating ALD pro-gression beside abstinence from alcohol. Further research is needed.
Date:	2021-11-01
Relation:	Drug and Alcohol Dependence. 2021 Nov 1;228:Article number 109096.
Link to:	http://dx.doi.org/10.1016/j.drugalcdep.2021.109096
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0376-8716&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000704374300009
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85115945766
Appears in Collections:	[Pau-Chung Chen] Periodical Articles

Files in This Item:

File	Description	Size	Format
ISI000704374300009.pdf		1040Kb	Adobe PDF	192	View/Open

Loading...